CDK9 and cancer: However, the data from genome-wide CRISPR-Cas9 screens indicate that in almost all cancer cell lines tested, including those used in the present study, genetic loss of CDK3 and CDK5 has a minimal impact on cell survival, in clear contrast to the marked dependency of cancer lines following genetic knockdown of CDK2 and especially CDK9.